| Line Item | 2025-12-31 | Y/Y |
|---|---|---|
| Revenue | $1.15B | +10.3% |
| Cost of Revenue | $516.2M | +8.1% |
| Gross Profit | $632.9M | +12.1% |
| R&D Expense | $152.3M | -8.3% |
| SG&A Expense | $139.9M | +1.7% |
| Operating Income | $28.9M | +156.2% |
| Pre-tax Income | $44.9M | +452.3% |
| Income Tax | $5.5M | — |
| Net Income | $39.4M |
| Line Item | 2025-12-31 | Y/Y |
|---|---|---|
| Cash & Equivalents | $232.1M | -36.0% |
| Accounts Receivable | $131.0M | +13.7% |
| Current Assets | $959.7M | -23.1% |
| Total Assets | $1.79B | -12.7% |
| Current Liabilities | $213.0M | -66.8% |
| Total Liabilities | $1.00B | -29.7% |
| Stockholders' Equity | $785.8M | +26.3% |
| Line Item | 2025-12-31 | Y/Y |
|---|---|---|
| Operating Cash Flow | $226.2M | +58.0% |
| Capital Expenditures | $25.0M | -41.1% |
| Investing Cash Flow | $122.3M | +145.9% |
| Financing Cash Flow | -$478.6M | -239.6% |
| Free Cash Flow | $201.2M | +99.7% |
| +408.1% |
| EPS (Basic) | $0.51 | +400.0% |
| EPS (Diluted) | $0.45 | +364.7% |